Deborah Cromer
Overview
Explore the profile of Deborah Cromer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
5047
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee W, Selva K, Audsley J, Kent H, Reynaldi A, Schlub T, et al.
JCI Insight
. 2025 Jan;
10(4).
PMID: 39786918
BACKGROUNDThe immunogenicity of current influenza vaccines needs improvement. Inactivated influenza and COVID-19 mRNA vaccines can be coadministered, but randomized controlled trial data are lacking on whether the 2 vaccines are...
2.
Claiborne D, Detwiler Z, Docken S, Borland T, Cromer D, Simkhovich A, et al.
Nat Commun
. 2025 Jan;
16(1):446.
PMID: 39774003
The only cure of HIV has been achieved in a small number of people who received a hematopoietic stem cell transplant (HSCT) comprising allogeneic cells carrying a rare, naturally occurring,...
3.
Cromer D, Reynaldi A, Mitchell A, Schlub T, Juno J, Wheatley A, et al.
Nat Commun
. 2024 Sep;
15(1):8395.
PMID: 39333473
The ongoing evolution of the SARS-CoV-2 virus has led to a move to update vaccine antigens in 2022 and 2023. These updated antigens were chosen and approved based largely on...
4.
Revoltar M, van der Linde R, Cromer D, Gatt P, Smith S, Fernandez M, et al.
Pathology
. 2024 Jul;
56(6):882-888.
PMID: 39025727
Measurable residual disease (MRD) is useful for prognostication and for monitoring response to treatment in patients with acute leukaemia. MRD by multiparametric flow cytometry (MFC-MRD) utilises the leukaemia-associated immunophenotype (LAIP)...
5.
Hastak P, Cromer D, Malycha J, Andersen C, Raith E, Davenport M, et al.
Sci Rep
. 2024 May;
14(1):11102.
PMID: 38750134
Lymphopenia is a common feature of acute COVID-19 and is associated with increased disease severity and 30-day mortality. Here we aim to define the demographic and clinical characteristics that correlate...
6.
Elias K, Khan S, Stadler E, Schlub T, Cromer D, Polizzotto M, et al.
Lancet Microbe
. 2024 Apr;
5(5):e459-e467.
PMID: 38583464
Background: Surrogates of antiviral efficacy are needed for COVID-19. We aimed to investigate the relationship between the virological effect of treatment and clinical efficacy as measured by progression to severe...
7.
Docken S, McCormick K, Pampena M, Samer S, Lindemuth E, Pinkevych M, et al.
PLoS Pathog
. 2023 Nov;
19(11):e1011755.
PMID: 38032851
HIV rapidly rebounds after interruption of antiretroviral therapy (ART). HIV-specific CD8+ T cells may act to prevent early events in viral reactivation. However, the presence of viral immune escape mutations...
8.
Stadler E, Chai K, Schlub T, Cromer D, Khan S, Polizzotto M, et al.
Lancet Microbe
. 2023 Nov;
4(11):e883-e892.
PMID: 37924835
Background: Randomised controlled trials of passive antibodies as treatment and prophylaxis for COVID-19 have reported variable efficacy. However, the determinants of efficacy have not been identified. We aimed to assess...
9.
Zachreson C, Tobin R, Szanyi J, Walker C, Cromer D, Shearer F, et al.
Vaccine
. 2023 Oct;
41(45):6630-6636.
PMID: 37793975
The ability for vaccines to protect against infectious diseases varies among individuals, but computational models employed to inform policy typically do not account for this variation. Here we examine this...
10.
Selva K, Ramanathan P, Haycroft E, Reynaldi A, Cromer D, Tan C, et al.
JCI Insight
. 2023 Sep;
8(18).
PMID: 37737263
Understanding mucosal antibody responses from SARS-CoV-2 infection and/or vaccination is crucial to develop strategies for longer term immunity, especially against emerging viral variants. We profiled serial paired mucosal and plasma...